energycommerce.house.gov · · 2014-04-23the process followed by fda in proposing this rule...

6

Upload: danghuong

Post on 23-Apr-2018

218 views

Category:

Documents

5 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: energycommerce.house.gov · · 2014-04-23The process followed by FDA in proposing this rule appears to stand in stark contrast to ... Director of FDA's Center for Drug Evaluation

Page 2: energycommerce.house.gov · · 2014-04-23The process followed by FDA in proposing this rule appears to stand in stark contrast to ... Director of FDA's Center for Drug Evaluation

Page 3: energycommerce.house.gov · · 2014-04-23The process followed by FDA in proposing this rule appears to stand in stark contrast to ... Director of FDA's Center for Drug Evaluation

Page 4: energycommerce.house.gov · · 2014-04-23The process followed by FDA in proposing this rule appears to stand in stark contrast to ... Director of FDA's Center for Drug Evaluation

Page 5: energycommerce.house.gov · · 2014-04-23The process followed by FDA in proposing this rule appears to stand in stark contrast to ... Director of FDA's Center for Drug Evaluation

Page 6: energycommerce.house.gov · · 2014-04-23The process followed by FDA in proposing this rule appears to stand in stark contrast to ... Director of FDA's Center for Drug Evaluation

DDI Webinar Series: An Overview of FDA's Expanded Access

FDA's warning against B-Perfect

Lifecycle Approach to FDA's Structured Benefit-Risk Assessment

for GMP of API FDA's Guidelines - Dalton

The fda's approach to enfocement is changing

GAO-12-116, Drug Shortages: FDA's Ability to Respond

Don't Try This at Home: The FDA's Restrictive Regulation

US FDA's Question-based Review for Generic Drugs - ICH

FDA's Regulatory Procedures Manual, Chapter 9 - Import

PEMD-89-10 Medical Devices: FDA's …regulation, (3) to evaluate FDA'S analysis and use of the MDR data, and (4) to review FDA's efforts to assess the degree to which medical device

FDA's Perspectives on Cross- Contamination in CMO ... · 1 FDA's Perspectives on Cross- Contamination in CMO Facilities, Considering High Risk Products Bo Chi, Ph.D. Biotech Manufacturing

Drug Safety Information – FDA's Communication to the Public

Strategies for meeting FDA's UDI Rule

FSMA: Understanding FDA's New Food Safety Rules

Drug Safety Information -- FDA's Communication to the Public (PDF

FDA's Module 1 Update: From Ideas to Implementation · FDA's Module 1 Update: From Ideas to Implementation ... (List related License Applications, INDs, NDAs, PMAs, 510(k), IDFs,

FDA's warning against new you

Cosmetic Labeling: The FDA's Response to Consumer Needs

FDA's Advice on Natural body solution

GAO-21-409T, DRUG SAFETY: FDA's Future Inspection Plans

Fda's warning against sliming diet

FDA's warning against asset bold

US FDA's PAT Guidance – 10 years and now

Drug Safety Information -- FDA's Communication to the Public (PDF

FDA's Advice on Slim trim u

FDA's notification on "Infinity"

Renew food facilities registration, FDA's Global ...36mfjx1a0yt01ki78v3bb46n15gp.wpengine.netdna-cdn.com/wp-content/...Renew food facilities' registration, FDA's Global Initiative,

FDA's Regulation Of Mobile Health

GAO-07-54 Prescription Drugs: Improvements Needed in FDA's

FDA's Overview of the Regulatory Guidance for the Development

GAO-11-556T Medical Devices: FDA's Premarket Review and

Regulatory Science in FDA's Center for Devices and Radiological

Time for Change: Stepping Up the FDA's Regulation of

PEMD-88-30 Medical Devices: FDA's Forecasts of Problem

Overview of FDA's Regulatory Framework for PET Drugs